Last updated: 2026-10-13 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Envoy Medical, Inc. (COCH) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalisation of $50.91M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.36 to $0.97. This page covers its latest market performance, valuation, price trends and company information.
$50.91M | |
$0.66 | |
$11.46 | |
$0.36 | |
$0.66 | |
137.63K | |
139.35K | |
-- | |
$0.97 | |
$0.36 | |
-- | |
-- |
Envoy Medical, Inc. (COCH) is trading at $0.64 in pre-market trading as of 2026-10-12 23:31:00, down 2.10% ($0.01) from the previous close of $0.66
Pre-market trading shows how investors are pricing COCH before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Envoy Medical, Inc. (COCH) moved from $0.68 to $0.65, representing a decline of 3.98% ($0.03).
The stock traded between $0.64 and $0.70 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 81.80 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 47.2%
COCH is currently trading at $0.65, placing it 47.2% of the way from its 52-week low of $0.36 to its 52-week high of $0.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 47 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Envoy Medical, Inc. (COCH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.